The Molecular Biology Society of Japan

[3LBA-115] New therapeutic strategy for acute myeloid leukemia (AML) using lysosomal function.

〇Aki Inase1, Yimamu Maimaitili1, Yu Mizutani1, Hironobu Minami1, Hiroshi Matsuoka1 (1.Div. Oncol./Hematology, Kobe Univ. Grad. Sch. Med.)

Gemtuzumab ozogamicin, mTORC1/2 inhibitor, AML, ADC

This archive has moved to the member page of The Molecular Biology Society of Japan.
Members can access the abstracts via links at the member page of the sites.
Please feel free to contact the journal offices for any inquiries.